Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $1.6800 (-1.75%) ($1.6800 - $1.6800) on Mon. Nov. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.01% (three month average) | RSI | 23 | Latest Price | $1.6800(-1.75%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ANPC declines -10.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) XLF(20%) EWG(19%) EMHY(18%) EWP(18%) JNK(18%) | Factors Impacting ANPC price | ANPC will decline at least -3.005% in a week (0% probabilities). SIL(-25%) SLV(-23%) BNDX(-18%) GDXJ(-17%) GDX(-17%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.005% (StdDev 6.01%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-33.52(-2095.24%) | Resistance Level | $2.03 | 5 Day Moving Average | $1.71(-1.75%) | 10 Day Moving Average | $1.72(-2.33%) | 20 Day Moving Average | $2.03(-17.24%) | To recent high | -51.7% | To recent low | 2.4% | Market Cap | $14m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |